levofloxacin has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, AC; Bennett, CL; Witherspoon, BJ | 1 |
| Chen, Y; Huang, H; Jiang, C; Lang, L; Wang, H; Wang, Y; Xu, Z; Zhao, Y | 1 |
1 trial(s) available for levofloxacin and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Idiopathic Pulmonary Fibrosis; Levofloxacin; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Diffusing Capacity; Tandem Mass Spectrometry; Tissue Distribution | 2014 |
1 other study(ies) available for levofloxacin and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and dru
Topics: Animals; Aortic Aneurysm; Ciprofloxacin; Dissection; Humans; Idiopathic Pulmonary Fibrosis; Levofloxacin; Moxifloxacin; United States; United States Food and Drug Administration | 2020 |